Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management.

Sahai A, Cortes E, Seth J, Khan MS, Panicker J, Kelleher C, Kessler TM, Fowler CJ, Dasgupta P.

Curr Urol Rep. 2011 Dec;12(6):404-12. doi: 10.1007/s11934-011-0221-1. Review.

PMID:
21964989
3.

Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.

Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D.

J Urol. 2000 Sep;164(3 Pt 1):692-7.

PMID:
10953127
4.

Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.

Chen G, Liao L.

Int Urol Nephrol. 2011 Sep;43(3):655-62. doi: 10.1007/s11255-010-9873-x. Epub 2010 Nov 26.

PMID:
21110094
5.

Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.

Mehta S, Hill D, McIntyre A, Foley N, Hsieh J, Ethans K, Teasell RW, Loh E, Welk B, Wolfe D.

Arch Phys Med Rehabil. 2013 Aug;94(8):1473-81. doi: 10.1016/j.apmr.2013.04.011. Epub 2013 Apr 28. Review.

PMID:
23632286
6.

Neurogenic bladder in spinal cord injury.

Samson G, Cardenas DD.

Phys Med Rehabil Clin N Am. 2007 May;18(2):255-74, vi. Review.

PMID:
17543772
7.

Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity.

Alvares RA, Silva JA, Barboza AL, Monteiro RT.

Int Braz J Urol. 2010 Nov-Dec;36(6):732-7.

8.

Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.

Goessaert AS, Everaert KC.

Expert Rev Neurother. 2012 Jul;12(7):763-75. doi: 10.1586/ern.12.61. Review.

PMID:
22853784
9.

Options for independent bladder management in patients with spinal cord injury and hand function prohibiting intermittent catheterization.

Sorokin I, De E.

Neurourol Urodyn. 2015 Feb;34(2):167-76. doi: 10.1002/nau.22516. Epub 2013 Oct 22. Review.

PMID:
24151101
10.
11.

Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.

Utomo E, Groen J, Blok BF.

Cochrane Database Syst Rev. 2014 May 24;(5):CD004927. doi: 10.1002/14651858.CD004927.pub4. Review.

PMID:
24859260
12.

The evaluation and management of refractory neurogenic overactive bladder.

Kurpad R, Kennelly MJ.

Curr Urol Rep. 2014 Oct;15(10):444. doi: 10.1007/s11934-014-0444-z. Review.

PMID:
25118853
13.

Botulinum toxin type A for neurogenic detrusor overactivity due to spinal cord lesions in children: a retrospective study of seven cases.

Do Ngoc Thanh C, Audry G, Forin V.

J Pediatr Urol. 2009 Dec;5(6):430-6. doi: 10.1016/j.jpurol.2009.06.001. Epub 2009 Jul 3.

PMID:
19577520
14.

Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review.

Linsenmeyer TA.

J Spinal Cord Med. 2013 Sep;36(5):402-19. doi: 10.1179/2045772313Y.0000000116. Review.

15.

Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.

Giannantoni A, Mearini E, Del Zingaro M, Porena M.

Eur Urol. 2009 Mar;55(3):705-11. doi: 10.1016/j.eururo.2008.08.048. Epub 2008 Sep 2.

PMID:
18814955
16.

Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore.

Tow AM, Toh KL, Chan SP, Consigliere D.

Ann Acad Med Singapore. 2007 Jan;36(1):11-7.

17.

The artificial somato-autonomic reflex arch does not improve lower urinary tract function in patients with spinal cord lesions.

Rasmussen MM, Rawashdeh YF, Clemmensen D, Tankisi H, Fuglsang-Frederiksen A, Krogh K, Christensen P.

J Urol. 2015 Feb;193(2):598-604. doi: 10.1016/j.juro.2014.08.090. Epub 2014 Aug 23.

PMID:
25158270
18.

Peripheral and Sacral Neuromodulation in the Treatment of Neurogenic Lower Urinary Tract Dysfunction.

Barboglio Romo PG, Gupta P.

Urol Clin North Am. 2017 Aug;44(3):453-461. doi: 10.1016/j.ucl.2017.04.011. Review.

PMID:
28716325
20.

Re: Opposing views T. B. Boone and I. Perkash J Urol 2009; 181: 1538-1540.

Pannek J.

J Urol. 2010 Jan;183(1):400-1; author reply 401-2. doi: 10.1016/j.juro.2009.09.005. No abstract available.

PMID:
19932493

Supplemental Content

Support Center